ES2181444T3 - Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. - Google Patents
Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias.Info
- Publication number
- ES2181444T3 ES2181444T3 ES99924991T ES99924991T ES2181444T3 ES 2181444 T3 ES2181444 T3 ES 2181444T3 ES 99924991 T ES99924991 T ES 99924991T ES 99924991 T ES99924991 T ES 99924991T ES 2181444 T3 ES2181444 T3 ES 2181444T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- tumor
- production
- neoplasias
- induction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Vacuna, que comprende un bacteriófago o un fragmento funcional equivalente del mismo, el cual expresa por lo menos, un antígeno específico de un tumor y/o un antígeno asociado a un tumor, con una longitud por lo menos de 20 aminoácidos, como proteína de fusión con una proteína de la envoltura del fago cpVIII ó un fragmento o un derivado funcional equivalente del mismo, sobre su superficie, y eventualmente contiene un soporte farmacéuticamente aceptable y/o un diluyente farmacéuticamente aceptable.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821925A DE19821925A1 (de) | 1998-05-15 | 1998-05-15 | Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien |
| EP9903353 | 1999-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2181444T3 true ES2181444T3 (es) | 2003-02-16 |
Family
ID=7867943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99924991T Expired - Lifetime ES2181444T3 (es) | 1998-05-15 | 1999-05-17 | Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1214942A3 (es) |
| AT (1) | ATE222772T1 (es) |
| AU (1) | AU764390B2 (es) |
| CA (1) | CA2328057A1 (es) |
| DE (2) | DE19821925A1 (es) |
| DK (1) | DK1077720T3 (es) |
| ES (1) | ES2181444T3 (es) |
| IL (1) | IL139683A0 (es) |
| WO (1) | WO1999059624A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003293958A1 (en) * | 2002-12-23 | 2004-07-22 | Apalexo Biotechnologie Gmbh | Purification of recombinant filamental bacteriophages by means of affinity chromatography to increase the immunogenicity and efficacy of phagic vaccines |
| CN114907472A (zh) * | 2022-04-07 | 2022-08-16 | 武汉爱博泰克生物科技有限公司 | 一种精准复制抗体的方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262177A (en) * | 1986-02-07 | 1993-11-16 | Oncogen | Recombinant viruses encoding the human melanoma-associated antigen |
| NZ219192A (en) * | 1986-02-07 | 1991-10-25 | Oncogen | Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines |
| GB9022190D0 (en) * | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
| US5674486A (en) * | 1991-06-25 | 1997-10-07 | San Diego Regional Cancer Center | Cancer immunotherapy with carrier cells |
| US5759535A (en) * | 1994-05-13 | 1998-06-02 | Research Corporation Technologies, Inc. | Immunotherapeutic strategies for the treatment of cancer |
-
1998
- 1998-05-15 DE DE19821925A patent/DE19821925A1/de not_active Ceased
-
1999
- 1999-05-17 WO PCT/EP1999/003380 patent/WO1999059624A2/de active IP Right Grant
- 1999-05-17 IL IL13968399A patent/IL139683A0/xx unknown
- 1999-05-17 CA CA002328057A patent/CA2328057A1/en not_active Abandoned
- 1999-05-17 DK DK99924991T patent/DK1077720T3/da active
- 1999-05-17 EP EP02003333A patent/EP1214942A3/de not_active Withdrawn
- 1999-05-17 AT AT99924991T patent/ATE222772T1/de not_active IP Right Cessation
- 1999-05-17 DE DE59902472T patent/DE59902472D1/de not_active Expired - Fee Related
- 1999-05-17 AU AU41442/99A patent/AU764390B2/en not_active Ceased
- 1999-05-17 EP EP99924991A patent/EP1077720B1/de not_active Expired - Lifetime
- 1999-05-17 ES ES99924991T patent/ES2181444T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE222772T1 (de) | 2002-09-15 |
| WO1999059624A3 (de) | 2000-01-27 |
| DE19821925A1 (de) | 1999-11-18 |
| AU764390B2 (en) | 2003-08-14 |
| EP1077720A2 (de) | 2001-02-28 |
| IL139683A0 (en) | 2002-02-10 |
| DE59902472D1 (de) | 2002-10-02 |
| EP1077720B1 (de) | 2002-08-28 |
| DK1077720T3 (da) | 2004-03-22 |
| EP1214942A3 (de) | 2002-10-02 |
| CA2328057A1 (en) | 1999-11-25 |
| EP1214942A2 (de) | 2002-06-19 |
| WO1999059624A2 (de) | 1999-11-25 |
| AU4144299A (en) | 1999-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE328095T1 (de) | Verbesserungen des stärkegehaltes von pflanzen | |
| NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
| ATE293690T1 (de) | Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie | |
| EP0681585A4 (en) | FACTORS ASSOCIATED TO TATA-BINDING PROTEINS, NUCLEIC ACIDS ENCODING TAFS AND METHODS FOR USE THEREOF. | |
| EP1214098A4 (en) | CAPSIDE-MODIFIED RECOMBINANT ADENOVIRUS AND METHOD FOR USE THEREOF | |
| WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
| HK1049185A1 (zh) | 可改螢光蛋白 | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| ATE309356T1 (de) | Konstruierte fluoreszenzproteine mit langen wellenlängen | |
| ES2181444T3 (es) | Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. | |
| DE59712554D1 (de) | Rekombinante expression von s-layer-proteinen | |
| HUP9901786A2 (hu) | Eljárás helypreferált rákos áttétképződéssel kapcsolatos gének azonosítására immuno-mágneses sejtszeparáció felhasználásával | |
| DE3882455D1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. | |
| EP0888374A4 (en) | NUCLEIC ACID LIGANDS WITH HIGH AFFINITY FOR THE PROTEINS OF THE COMPLEMENT SYSTEM | |
| PT870015E (pt) | Novas xilanases os genes que as codificam e as suas utilizacoes | |
| FR2709132B1 (fr) | Fragment d'ADN portant le gène codant pour l'enzyme de fragmentation du N-acétylhéparosane et les séquences adjacentes permettant son expression, enzyme recombinée et son utilisation. | |
| WO2000053785A3 (en) | Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins | |
| IT8521507A0 (it) | Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni. | |
| ATE327334T1 (de) | Atp- und nukleinsäure-bindendes protein mit helikase- und atpase eigenschaften | |
| DE60134956D1 (de) | Gene differentiell experimiert in brudtkrebs | |
| WO2002006340A3 (en) | Tetraspan protein and uses thereof | |
| DK1214453T3 (da) | Hidtil ukendte cellecykluskontrolpunktgener og proteiner kodet deraf | |
| CA2347371A1 (en) | HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE | |
| BR9810643A (pt) | Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos | |
| WO2006073587A3 (en) | Hemipteran 5-hydroxytryptamine 7 serotonin receptor |